- Home
- IZEA vs NRXP Comparison
IZEA vs NRXP Comparison
Compare IZEA & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZEA
- NRXP
- Stock Information
- Founded
- IZEA 2006
- NRXP 2015
- Country
- IZEA United States
- NRXP United States
- Employees
- IZEA N/A
- NRXP N/A
- Industry
- IZEA Advertising
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- IZEA Consumer Discretionary
- NRXP Health Care
- Exchange
- IZEA Nasdaq
- NRXP Nasdaq
- Market Cap
- IZEA 44.6M
- NRXP 32.6M
- IPO Year
- IZEA N/A
- NRXP N/A
- Fundamental
- Price
- IZEA $3.38
- NRXP $2.94
- Analyst Decision
- IZEA
- NRXP Strong Buy
- Analyst Count
- IZEA 0
- NRXP 4
- Target Price
- IZEA N/A
- NRXP $28.50
- AVG Volume (30 Days)
- IZEA 58.9K
- NRXP 189.6K
- Earning Date
- IZEA 08-13-2025
- NRXP 08-13-2025
- Dividend Yield
- IZEA N/A
- NRXP N/A
- EPS Growth
- IZEA N/A
- NRXP N/A
- EPS
- IZEA N/A
- NRXP N/A
- Revenue
- IZEA $36,896,490.00
- NRXP N/A
- Revenue This Year
- IZEA $16.46
- NRXP N/A
- Revenue Next Year
- IZEA $15.95
- NRXP N/A
- P/E Ratio
- IZEA N/A
- NRXP N/A
- Revenue Growth
- IZEA 7.17
- NRXP N/A
- 52 Week Low
- IZEA $1.68
- NRXP $1.10
- 52 Week High
- IZEA $3.52
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- IZEA 78.20
- NRXP 40.46
- Support Level
- IZEA $2.55
- NRXP $3.12
- Resistance Level
- IZEA $3.52
- NRXP $3.53
- Average True Range (ATR)
- IZEA 0.17
- NRXP 0.16
- MACD
- IZEA 0.08
- NRXP -0.07
- Stochastic Oscillator
- IZEA 94.12
- NRXP 8.62
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.